Quality of life among patients with beta-thalassemia major in Shahrekord city, Iran

Authors

Abstract:

Background and aims: Nowadays introduction of regular blood transfusion therapy has obviously improved the life expectancy of patients with thalassemia. However, these patients face with newer challenges which influence their quality of life (QoL). In this study, the aim of this study was to measure QoL among patients with β-thalassemia major (β-TM). Methods: A cross-sectional study was done at the thalassemia centre of Shahrekord University of Medical Sciences. All the forty patients with β-thalassemia which were more than 12 years old referred to blood transfusion and participated in this study. Then, they were asked to fill out the Short Form Health Status Survey (SF-36) questionnaire. The questionnaire evaluates 8 health areas including physical functioning (PF), role-physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role-emotional (RE) and mental health (MH). The scores of each participant were calculated and data were analyzed using SPSS. Results: There were 18 men and 22 women, and the mean age was 21.69±5.74 years (range 12-38). No significant difference was seen in QoL between men and women (68.72±19.79 versus 67.47±18.80, P=0.84). The mean±SD score of PF, RP, BP, GH, VT, SF, MH was 80.5±16, 83.75±29.17, 71.94±24.22, 57.48±23.93, 54.36±22.51, 68.94±23.37, 66.33±36.04 and 58.51±23.68, respectivly. No significant differences were detected in all mentioned scores between men and women (P>0.05). Conclusion: Although most of the participants had suitable physical functioning, thalassemia had a negative effect on emotional role, social functioning and mental health of patients. It shows the importance of psychosocial supports for these patients.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

quality of life among patients with beta-thalassemia major in shahrekord city, iran

background and aims: nowadays introduction of regular blood transfusion therapy has obviously improved the life expectancy of patients with thalassemia. however, these patients face with newer challenges which influence their quality of life (qol). in this study, the aim of this study was to measure qol among patients with β-thalassemia major (β-tm). methods: a cross-sectional study was done at...

full text

Quality of Life and Some Related Factors in Patients With Beta Thalassemia Major in Southwest Iran

Background: Thalassemia is one of the most common genetic disorders in the world, especially in Iran. The study of various aspects affecting the physical and mental health of patients with beta thalassemia major has become more important. The aim of this study was to evaluate the Quality of life and some related factors in patients with beta-thalassemia major in Southwest Iran. Methods: In thi...

full text

Quality of Life in Patients Suffering from Beta-Thalassemia Major in Amirkola, Iran

Abstract Introduction: Thalassemia is regarded as a genetic hematologic disease that affects various aspects of patients’ life. Measuring the health-related quality of life is a multidimensional concept that focuses on the disease as well as its treatment. Materials and methods:  This  cross-sectional study consisted of  50 adolescents aged 12-18 years suffering from Thalassemia major, ou...

full text

Quality of life in patients with thalassemia major

Background With modern medical management, thalassemia major is now extending into adulthood and it is expected to have a negative impact on the quality of life (QOL) of the patients. The aim of this study was to evaluate quality of life in patients with thalassemia major. Materials and Methods This is an analytic case control study. Two hundred and fifty patients and 51 participants a...

full text

Seroprevalence of HCV antibody among patients with beta-thalassemia major in Amirkola Thalassemia Center, Iran.

beta- thalassemia major is a common hemoglobinopathy in humans. In some journals, numerous studies have reported different prevalence of hepatitis C among beta- thalassemia major because thalassemic patients need multiple blood transfusions and blood transfusion is a common transmission pathway for hepatitis C virus. Thus this study was performed for detection of anti-HCV between beta- thalasse...

full text

Malignancies in patients with beta-thalassemia major and beta-thalassemia intermedia: a multicenter study in Iran.

BACKGROUND Beta thalassemia is one of the most common genetic disorders in the world. The aim of this study was to determine the frequency, characteristics, and pattern of malignancies in patients with beta thalassemia major (BTM) and beta thalassemia intermedia (BTI) in Iran. METHODS We conducted a multicenter study via a retrospective chart review of patients with BTM and BTI between 2002 a...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 3  issue 4

pages  324- 328

publication date 2016-11-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023